Litcius/Paper detail

Proteolysis-targeting chimera-doxorubicin conjugate nanoassemblies for dual treatment of EGFR-TKI sensitive and resistant non-small cell lung cancer

Junhui Ma, Ruixue Zhu, Meijing Li, Hui Jiao, Sijun Fan, Xiang Ma, Guangya Xiang, Guangya Xiang

2025Acta Biomaterialia16 citationsDOI

Topics & Concepts

Chimera (genetics)ConjugateCancer researchMaterials scienceDoxorubicinProteolysisLung cancerMedicineOncologyChemistryInternal medicineChemotherapyBiochemistryEnzymeGeneMathematical analysisMathematicsLung Cancer Research StudiesLung Cancer Treatments and MutationsPeptidase Inhibition and Analysis
Proteolysis-targeting chimera-doxorubicin conjugate nanoassemblies for dual treatment of EGFR-TKI sensitive and resistant non-small cell lung cancer | Litcius